Paris · Growth · 17 people tracked
Find your way into Lauxera Capital Partners
Sign up to see every warm intro you have to Lauxera Capital Partners
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lauxera Capital Partners team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Lauxera invests in healthtech businesses that have reached early profitability, aiming to catalyze inflections in growth through new innovation, commercial investment, business development, and stronger talent. The firm partners with founders and world-class managers, contributing both capital and operational expertise to improve the efficiency of the healthtech system, save lives, and reduce costs. Its team combines entrepreneurial company builders with experienced investors who have guided healthtech companies across all growth stages. Lauxera operates from offices in Europe and the United States and targets investment tickets ranging from roughly 20 to 100 million euros.
Source: firm website, verified Sep 29, 2026.
Team · 17 people
from the firm's website & curatedFounder mafia
4 people who came through Lauxera Capital Partners went on to found or lead other companies.
What they invest in
from 12 of 17 portfolio companiesHealthtech ×9Medical Devices ×9Digital Health ×7Biotech ×6AI & Machine Learning ×3SaaS ×3Deep Tech ×2Cloud Computing ×1
HQs:France×2United States×2Germany×1Denmark×1United Kingdom×1Sweden×1
Who they back
founder profiles across 10 portfolio companiesFounding team size:solo founder×32 founders×64+ founders×1
What their founders studiedfrom 10 founders with field-of-study data
Business & Management ×3Computer Science ×3Life Sciences ×2Physics ×2
Investments · 17 tracked
founders shown can be your intro pathBy year:2025 · 12024 · 12023 · 12022 · 12021 · 32019 · 18 dated
Matrix Req is AI-powered software for medical device companies to manage requirements, specifications, risks, and test cases with complete traceability and automated compliance checking across global regulatory standards.
AI & Machine LearningCloud ComputingEnterprise SoftwareHealthtechMedical DevicesSaaSKehl, DE
Yves Berquin(Co-founder)inWolfgang Huber(Co-founder)in
Reapplix develops advanced wound care products and therapeutics for clinical use.
BiotechHealthtechMedical DevicesDenmark, DK
Niels Erik Holm(Co-founder)Rasmus Lundquist(Chief Scientific Officer)in
Co-investorsSeed Capital Limited
Antaros Medical is a development partner to the pharmaceutical industry that uses medical imaging to provide evidence-based decision support during clinical drug development.
BiotechDigital HealthHealthtechMedical Devices
BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications.
BiotechDeep TechDigital HealthHealthtechMedical DevicesNew MaterialsStockholm, SE
Kristian Tryggvason(Founder and Board Member)inKarl Tryggvason
Co-investorsEuropean Investment Bank
Digital health platform using AI to analyze video, audio, image and device data in the operating room to improve surgical outcomes and patient safety.
HealthtechBoston, US
Bjoern von Siemens(Executive Officer, Director)inDennis Kogan(Executive Officer, Director)Filip Pintelon(Director)inWerner Zoellner(Director)Paul Summerside(Director)Timothy Lantz(Executive Officer)
Co-investorsEckuityEczacibasi Momentum Teknoloji YatimlariHarmonix FundIntel CapitalNeventa CapitalOptum Ventures+1 more
Digital Surgery develops pulsed field ablation technologies for the treatment of atrial fibrillation, offering safer and more effective procedural options for cardiac patients.
AI & Machine LearningDigital HealthMedical Devices
Co-investors8VCBalderton CapitalXR InvestBlackRockFrstIndex Ventures+4 more
Lifen provides digital tools for accessing and managing medical documents, serving patients and healthcare providers in France.
Digital HealthHealthtechSaaSParis, FR
Alexandre Huckert(Founder)inFranck Le Ouay(Founder)in
Co-investorsAgoranovDaphniKickstart InnovationPartech VenturesSerenaCreadev+1 more
Alexandre Huckert(Founder)Etienne Depaulis(Founder)Franck Le Ouay(Founder)in
Co-investorsPartech VenturesSerena
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level.
BiotechDeep TechHardwareMedical Devices
Andrea(Co-founder & Chief Scientific Officer)Gerrit(Co-founder & Director of Product Management and Marketing)Hugo(CEO)Edmee(Chief Financial Officer)Hannah(HR Director)
Co-investorsSoftBank Vision FundEuropean Investment BankGilde HealthcareIrving InvestorsPura Vida InvestmentsT. Rowe Price
Natural Cycles offers an FDA-cleared mobile app that uses a user's body temperature data and an algorithm to predict fertile windows for hormone-free birth control and pregnancy planning.
Digital HealthFemTechMedical Devices
Dr. Elina Berglund Scherwitzl(Co-founder and CEO)inRaoul Scherwitzl(Founder)inElina Berglund(Founder)Elina Berglund Scherwitzl(Founder)
Co-investorsBonnier CapitalHeadlineHeadline Growth Management, LLCHeartcore CapitalBonnier VenturesEQT Ventures+2 more
OrganOx develops the metra platform, a device that extends organ preservation time for liver transplants by maintaining continuous perfusion with oxygenated blood-based solutions, enabling surgeons to better assess organ viability and make more informed transplant decisions.
BiotechHealthtechMedical DevicesOxford, GB
Prof. Peter Friend(Co-Founder)
Co-investorsAmadeus Capital PartnersAnjostBusiness Growth FundHealthQuest CapitalIntuitive VenturesLongwall Venture Partners LLP+2 more
Rubis Santé is a healthcare logistics and patient transport coordination platform designed for hospitals and medical facilities.
AI & Machine LearningDigital HealthHealthtechLogistics & Supply ChainSaaS
Jérémy Wies(Founder)in
Veranex provides multi-disciplinary services to medical device and healthcare companies, supporting them from concept through commercialization of medical innovations.
BiotechDigital HealthHealthtechMedical DevicesRaleigh, US
Patrick K. Donnelly(Founder)inMegan Osorio(Chief Executive Officer)inJose Pablo Morales(Chief Medical Officer)inBeth Moeller(Chief Commercial Officer)inDavid Dockhorn(Chief Operating Officer)inManasi Ramanna(Chief Financial Officer)in
Co-investorsSummit PartnersAccelmed Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AcandisOspiQuantiumportalVerdot
Exits · 1
1 acquisitionsDigital Surgeryacq. by Medtronic
Portfolio news
latest coverage across their companiesBioLamina · eu-startups.com · Apr 17, 2026
OrganOx · eu-startups.com · Aug 25, 2025
Antaros Medical · antarosmedical.com · Jul 15, 2025
Frequently asked questions
- How many investments has Lauxera Capital Partners made?
- Lauxera Capital Partners has 17 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
- What stage does Lauxera Capital Partners invest at?
- Lauxera Capital Partners invests at the Growth stage.
- What is Lauxera Capital Partners's typical check size?
- Lauxera Capital Partners typically writes checks of $22M – $110M.
- What sectors does Lauxera Capital Partners focus on?
- Lauxera Capital Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Lauxera Capital Partners located?
- Lauxera Capital Partners is headquartered in Paris, FR.
- Does Lauxera Capital Partners lead rounds?
- Yes, Lauxera Capital Partners leads investment rounds.
- Who does Lauxera Capital Partners co-invest with?
- Lauxera Capital Partners most often shares deals with Amadeus Capital Partners, Daphni, Intel Capital, among 29 tracked co-investors.
Media · Podcasts & interviews
featuring the teamSMART BOURSE - Marchés à thème(s) : Pierre Moustial (Lauxera Capital Partners)
B SMART · Pierre Moustial
Pierre Moustial (Lauxera Capital Partners) & Martial Descoutures (Oddo BHF): Le journal des Biotechs
Boursorama · Pierre Moustial
BE SMART - L'interview de Pierre Moustial (Lauxera Capital Partners) par Stéphane Soumier
B SMART · Pierre Moustial
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.







































































.jpeg)
